Meaning: In patients with advanced chronic kidney disease, compared with placebo, low-dose rivaroxaban did not reduce cardiovascular events, but increased rates of major bleeding
Eric Goldstein, a gastroenterologist in New York City, told Insider that while digestive issues are known side effects of this class of drugs, called GLP-1 receptor agonists, how widespread and severe they are is likely overblown on social media
Cardiovascular outcomes have been studied in diabetes programs, but long-term cardiovascular and renal effects need continued follow-up through registries and post-marketing safety data
Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P
To learn more about how Dr
Patients appreciate feeling better while they slim down